{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:41:44Z","timestamp":1768344104466,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T00:00:00Z","timestamp":1342742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1472-6947-12-75","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T22:12:46Z","timestamp":1342822366000},"source":"Crossref","is-referenced-by-count":32,"title":["Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? a qualitative study"],"prefix":"10.1186","volume":"12","author":[{"given":"Miriam J","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sheard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Maraveyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Noble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Prout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Watt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Dowding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,20]]},"reference":[{"issue":"6","key":"528_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/archinte.158.6.585","volume":"158","author":"MD Silverstein","year":"1998","unstructured":"Silverstein MD, Heit JA, Mohr DN, Petterson TM, O\u2019Fallon WM, Melton LJ: Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998, 158 (6): 585-593. 10.1001\/archinte.158.6.585.","journal-title":"Arch Intern Med"},{"issue":"23 Suppl 1","key":"528_CR2","first-page":"I4","volume":"107","author":"RH White","year":"2003","unstructured":"White RH: The epidemiology of venous thromboembolism. Circulation. 2003, 107 (23 Suppl 1): I4-I8.","journal-title":"Circulation"},{"issue":"5","key":"528_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","volume":"78","author":"N Levitan","year":"1999","unstructured":"Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R: Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999, 78 (5): 285-291. 10.1097\/00005792-199909000-00001.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"528_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ajcp\/71.1.10","volume":"71","author":"NC Sun","year":"1979","unstructured":"Sun NC, McAfee WM, Hum GJ, Weiner JM: Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol. 1979, 71 (1): 10-16.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"528_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/clon.1999.9023","volume":"11","author":"MJ Johnson","year":"1999","unstructured":"Johnson MJ, Sproule MW, Paul J: The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer. Clin Oncol (R Coll Radiol). 1999, 11 (2): 105-110. 10.1053\/clon.1999.9023.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"528_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.2005.05856.x","volume":"132","author":"TP Baglin","year":"2006","unstructured":"Baglin TP, Keeling DM, Watson HG: Guidelines on oral anticoagulation (warfarin): third edition\u20132005 update. Br J Haematol. 2006, 132 (3): 277-285. 10.1111\/j.1365-2141.2005.05856.x.","journal-title":"Br J Haematol"},{"issue":"4","key":"528_CR7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1055\/s-0038-1649881","volume":"74","author":"RD Bona","year":"1995","unstructured":"Bona RD, Sivjee KY, Hickey AD, Wallace DM, Wajcs SB: The efficacy and safety of oral anticoagulation in patients with cancer. Thromb Haemost. 1995, 74 (4): 1055-1058.","journal-title":"Thromb Haemost"},{"issue":"4","key":"528_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/1076029606293692","volume":"12","author":"SR Deitcher","year":"2006","unstructured":"Deitcher SR, Kessler CM, Merli G, Rigas JR, Lyons RM, Fareed J: Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period. Clin Appl Thromb Hemost. 2006, 12 (4): 389-396. 10.1177\/1076029606293692.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"12","key":"528_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.amjmed.2006.02.022","volume":"119","author":"RD Hull","year":"2006","unstructured":"Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, Dear R: Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med. 2006, 119 (12): 1062-1072. 10.1016\/j.amjmed.2006.02.022.","journal-title":"Am J Med"},{"issue":"17","key":"528_CR10","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","volume":"18","author":"BA Hutten","year":"2000","unstructured":"Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR: Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol. 2000, 18 (17): 3078-3083.","journal-title":"J Clin Oncol"},{"issue":"2","key":"528_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMoa025313","volume":"349","author":"AY Lee","year":"2003","unstructured":"Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M: Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003, 349 (2): 146-153. 10.1056\/NEJMoa025313.","journal-title":"N Engl J Med"},{"issue":"15","key":"528_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","volume":"162","author":"G Meyer","year":"2002","unstructured":"Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P: Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med. 2002, 162 (15): 1729-1735. 10.1001\/archinte.162.15.1729.","journal-title":"Arch Intern Med"},{"issue":"10","key":"528_CR13","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B: Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002, 100 (10): 3484-3488. 10.1182\/blood-2002-01-0108.","journal-title":"Blood"},{"issue":"3 Suppl","key":"528_CR14","doi-asserted-by":"publisher","first-page":"401S","DOI":"10.1378\/chest.126.3_suppl.401S","volume":"126","author":"HR Buller","year":"2004","unstructured":"Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE: Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126 (3 Suppl): 401S-428S.","journal-title":"Chest"},{"issue":"34","key":"528_CR15","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1200\/JCO.2007.14.1283","volume":"25","author":"GH Lyman","year":"2007","unstructured":"Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M: American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007, 25 (34): 5490-5505. 10.1200\/JCO.2007.14.1283.","journal-title":"J Clin Oncol"},{"issue":"3","key":"528_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.critrevonc.2006.05.001","volume":"59","author":"M Mandala","year":"2006","unstructured":"Mandala M, Falanga A, Piccioli A, Prandoni P, Pogliani EM, Labianca R: Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM). Crit Rev Oncol Hematol. 2006, 59 (3): 194-204. 10.1016\/j.critrevonc.2006.05.001.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"528_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1470-2045(08)70149-9","volume":"9","author":"SI Noble","year":"2008","unstructured":"Noble SI, Shelley MD, Coles B, Williams SM, Wilcock A, Johnson MJ: Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis. Lancet Oncol. 2008, 9 (6): 577-584. 10.1016\/S1470-2045(08)70149-9.","journal-title":"Lancet Oncol"},{"issue":"3","key":"528_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.7326\/0003-4819-146-3-200702060-00150","volume":"146","author":"JB Segal","year":"2007","unstructured":"Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB: Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007, 146 (3): 211-222.","journal-title":"Ann Intern Med"},{"issue":"985","key":"528_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/pgmj.2007.061622","volume":"83","author":"S Noble","year":"2007","unstructured":"Noble S: The challenges of managing cancer related venous thromboembolism in the palliative care setting. Postgrad Med J. 2007, 83 (985): 671-674. 10.1136\/pgmj.2007.061622.","journal-title":"Postgrad Med J"},{"issue":"6","key":"528_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/026921639701100606","volume":"11","author":"MJ Johnson","year":"1997","unstructured":"Johnson MJ, Sherry K: How do palliative physicians manage venous thromboembolism?. Palliat Med. 1997, 11 (6): 462-468. 10.1177\/026921639701100606.","journal-title":"Palliat Med"},{"key":"528_CR21","volume-title":"Venous Thromboembolism Registry) Fourth Annual Report","author":"VERITY","year":"2007","unstructured":"VERITY: Venous Thromboembolism Registry) Fourth Annual Report. 2007, \n                    http:\/\/www.verityonlinecouk\/modules\/PrivateSite\/Ficheros\/Publications_233\/Chapter%20Four%20-%20VTE%20&%20CANCERpdf\n                    \n                   2007Available from: URL:\n                    http:\/\/www.verityonline.co.uk\n                    \n                  , Chapter 4. VTE and cancer,"},{"key":"528_CR22","unstructured":"National Institute for Health and Clinical Excellence: How to change practice: understand, identify and overcome barriers to change.\n                    http:\/\/www.niceorguk\/media\/D33\/8D\/Howtochangepractice1pdf2007\n                    \n                  ,"},{"issue":"1","key":"528_CR23","first-page":"1","volume":"5","author":"NHS centre for reviews and dissemination","year":"1999","unstructured":"NHS centre for reviews and dissemination: Getting evidence into practice. Effective Health Care. 1999, 5 (1): 1-16.","journal-title":"Effective Health Care"},{"issue":"4","key":"528_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/104973239300300403","volume":"3","author":"ME Fonteyn","year":"1993","unstructured":"Fonteyn ME, Kuipers B, Grobe SJ: A description of think aloud method and protocol analysis. Qual Heal Res. 1993, 3 (4): 430-441. 10.1177\/104973239300300403.","journal-title":"Qual Heal Res"},{"key":"528_CR25","volume-title":"Analyzing Qualitative Data","author":"J Ritchie","year":"1994","unstructured":"Ritchie J, Spencer L: Qualitative data analysis for applied policy research. Analyzing Qualitative Data. Edited by: Bryman A, Burgess R. 1994, Routledge, London"},{"issue":"3","key":"528_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2753.1996.tb00047.x","volume":"2","author":"D Lamond","year":"1996","unstructured":"Lamond D, Crow R, Chase J: Judgements and processes in care decisions in acute medical and surgical wards. J Eval Clin Pract. 1996, 2 (3): 211-216. 10.1111\/j.1365-2753.1996.tb00047.x.","journal-title":"J Eval Clin Pract"},{"issue":"10","key":"528_CR27","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/j.1365-2702.2006.01453.x","volume":"15","author":"A Twycross","year":"2006","unstructured":"Twycross A, Powls L: How do children\u2019s nurses make clinical decisions? Two preliminary studies. J Clin Nurs. 2006, 15 (10): 1324-1335. 10.1111\/j.1365-2702.2006.01453.x.","journal-title":"J Clin Nurs"},{"key":"528_CR28","volume-title":"Shared care information on the prescribing of enoxaparin","author":"Plymouth Health Community","year":"2011","unstructured":"Plymouth Health Community: Shared care information on the prescribing of enoxaparin. 2011, NHS Plymouth Health Community, [cited 2011 Oct 27];Available from: URL:\n                    http:\/\/www.plymouthformulary.nhs.uk\/Shared-care-information-on-the-prescribing-of-enoxaparin\/\n                    \n                  ,"},{"key":"528_CR29","volume-title":"Shared Care Protocol between Sheffield Teaching Hospitals NHS Foundation Trust and NHS Sheffield for the prescription and supply of Enoxaparin (Clexane\u00ae)","author":"R Maclean","year":"2011","unstructured":"Maclean R: Shared Care Protocol between Sheffield Teaching Hospitals NHS Foundation Trust and NHS Sheffield for the prescription and supply of Enoxaparin (Clexane\u00ae). 2011, The Sheffield Area Prescribing Committee, Available from: URL:\n                    http:\/\/www.sheffield.nhs.uk\/professionals\/resources\/scps\/scpenoxaparin.pdf\n                    \n                  ,"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-12-75\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-75","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T15:32:28Z","timestamp":1548171148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-12-75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["528"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-12-75","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,20]]},"article-number":"75"}}